Montreal, Canada

Pasquale Forgione

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Pasquale Forgione: Innovator in Viral Polymerase Inhibitors

Introduction

Pasquale Forgione is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of viral polymerase inhibitors. With a total of 8 patents to his name, Forgione's work has the potential to impact the treatment of viral infections, including hepatitis C.

Latest Patents

Among his latest patents, Forgione has developed compounds that serve as inhibitors of the hepatitis C virus NS5B polymerase. These compounds are defined by a specific formula, wherein various components are tailored to enhance their efficacy against the virus. His innovative approach in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Forgione has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Forgione has had the opportunity to work alongside talented individuals such as Montse Llinas-Brunet and Jean Rancourt. These collaborations have enriched his research and fostered an environment of innovation and creativity.

Conclusion

Pasquale Forgione's contributions to the field of viral polymerase inhibitors highlight his role as a key innovator in medicinal chemistry. His patents and collaborations reflect a dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…